Sudipa Sarkar,Todd T Brown
Sudipa Sarkar
Comorbid conditions have a major impact on the health, quality of life, and survival of people with HIV (PWH), particularly as they age. The 2024 Conference on Retroviruses and Opportunistic Infections (CROI) featured many excellent reports...
CROI 2024: Tuberculosis, Mpox, and Other Infectious Complications in People With HIV [0.03%]
2024年CROI会议：HIV患者中的结核病、猴痘和其他感染并发症
Andrew D Kerkhoff,Jason Zucker,Diane V Havlir
Andrew D Kerkhoff
Several novel antituberculosis agents, including long-acting injectable agents in mouse models, have shown promise in preclinical and early clinical studies. This encouraging news is offset by the failures of a tuberculosis (TB) vaccine to ...
Mario Stevenson
Mario Stevenson
Scientists from around the world gathered in Denver for the Conference on Retroviruses and Opportunistic Infections (CROI). The conference maintained its existing format and used a combination of plenary lectures, workshops, oral abstract s...
CROI 2024: Global Epidemiology and Prevention of HIV and Other Sexually Transmitted Diseases [0.03%]
2024年逆转录病毒和机会性感染大会(CROI)：艾滋病和其他性传播疾病的全球流行病学和预防
Albert Y Liu,Susan P Buchbinder
Albert Y Liu
At the 2024 Conference on Retroviruses and Opportunistic Infections (CROI), investigators presented updates on the global HIV epidemic, focusing on ongoing disparities by race/ethnicity in the US, the ongoing concentration of new infections...
The Challenge of Adherence to a Complex Antiretroviral Therapy Regimen in an Individual With Multidrug-Resistant HIV [0.03%]
多重耐药HIV患者坚持复杂抗逆转录病毒治疗方案的挑战
Marco Moretti,Karolien Stoffels,Kristel Van Laethem et al.
Marco Moretti et al.
Limited therapeutic options are available for patients with multidrug-resistant HIV. This report describes a 38-year-old female who was perinatally infected with HIV-1 and treated with 14 different antiretroviral regimens over 27 years, gra...
Case Reports
Topics in antiviral medicine. 2024 Apr 18;32(2):437-444. DOI: 2024
Long-Term Effects of COVID-19: The Stories of 2 Physicians Who Became Patients [0.03%]
新冠肺炎的长期影响：两位医生患者的亲身经历
James Mwangi,Jeffrey N Siegelman
James Mwangi
Approximately 10% of patients who survive COVID-19 will proceed to have lasting, often debilitating effects, known as "long COVID." These symptoms can take various forms, most commonly including postexertional malaise, fatigue, brain fog, d...
Case Reports
Topics in antiviral medicine. 2024 Apr 18;32(2):431-436. DOI: 2024
Messenger RNA Vaccine Technology: Success for SARS-CoV-2 and Prospects for an HIV-1 Vaccine [0.03%]
信使核糖核酸疫苗技术：SARS-CoV-2成功的经验及其对HIV-1疫苗的启示
Jacob K Files,Paul A Goepfert
Jacob K Files
Over the past several years, messenger RNA (mRNA) vaccine has evolved from a term familiar only to vaccine scientists into one easily recognized by much of the general population. This change occurred because of the remarkable success of ef...
Hillary A Dunlevy,Steven C Johnson
Hillary A Dunlevy
Vaccinations are an important part of primary care for people with HIV (PWH) and can protect against viral hepatitis and some sexually transmitted infections, as well as respiratory bacterial and viral infections. Vaccinations for influenza...
2023 updated guidelines on infant feeding and HIV in the United States: what are they and why have recommendations changed [0.03%]
美国2023年更新的关于婴儿喂养和HIV的指南：内容是什么以及为何建议发生变化
Lealah Pollock,July Levison
Lealah Pollock
The US Department of Health and Human Services guidelines on infant feeding among people with HIV have changed in response to (1) evidence of low risk of transmission via breast milk among individuals with consistent viral suppression, (2) ...
Doxycycline postexposure prophylaxis for prevention of sexually transmitted infections [0.03%]
多西环素作为暴露后预防用药预防性传播感染性疾病
Chase A Cannon,Connie L Celum
Chase A Cannon
Doxycycline postexposure prophylaxis (doxy-PEP) is a novel strategy now demonstrated in several clinical trials to dramatically reduce incidence rates of gonorrhea, chlamydia, and syphilis in some key populations at high risk of sexually tr...